Díaz-Aragón A, Ruiz-Gastélum E, Álvarez-López H

Idioma: Inglés [English version]
Referencias bibliográficas: 20
Paginas: s147-152
Archivo PDF: 187.86 Kb.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Daniels TF, Killinger KM, Michal JJ, Wright RW, Jiang Z. Lipoproteins, cholesterol homeostasis and cardiac health. Int J Biol Sci. 2009; 5: 474-488.

2. Ballantyne CM. Clinical lipidology: companion to Braunwald's heart disease. Philadelphia, PA: Elsevier; 2008.

3. Feingold KR. Introduction to lipids and lipoproteins [Updated 2021 Jan 19]. In: Feingold KR, Anawalt B, Boyce A et al, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000. Available in: https://www.ncbi.nlm.nih.gov/books/NBK305896/

4. Green PH, Glickman RM. Intestinal lipoprotein metabolism. J Lipid Res. 1981; 22: 1153-1173.

5. Altmann SW, Davis HR Jr, Zhu LJ, Yao X, Hoos LM, Tetzloff G et al. Niemann-Pick C1 Like1 protein is critical for intestinal cholesterol absorption. Science. 2004; 303: 1201-1204.

6. Temel RE, Gebre AK, Parks JS, Rudel LL. Compared with Acyl-CoA: cholesterol O-acyltransferase (ACAT) 1 and lecithin: cholesterol acyltransferase, ACAT2 displays the greatest capacity to differentiate cholesterol from sitosterol. J Biol Chem. 2003; 278: 47594-47601.

7. Merkel M, Eckel RH, Goldberg IJ. Lipoprotein lipase: genetics, lipid uptake, and regulation. J Lipid Res. 2002; 43: 1997-2006.

8. Mead JR, Irvine SA, Ramji DP. Lipoprotein lipase: structure, function, regulation, and role in disease. J Mol Med. 2002; 80: 753-769.

9. Shelness GS, Sellers JA. Very-low-density lipoprotein assembly and secretion. Curr Opin Lipidol. 2001; 12: 151-157.

10. Nordestgaard BG, Varbo A. Triglycerides and cardiovascular disease. Lancet. 2014; 384: 626-635.

11. Valdemarsson S, Hansson P, Hedner P, Nilsson-Ehle P. Relations between thyroid function, hepatic and lipoprotein lipase activities, and plasma lipoprotein concentrations. Acta Endocrinol. 1983; 104: 50-56.

12. Kobayashi J, Miyashita K, Nakajima K, Mabuchi H. Hepatic lipase: a comprehensive view of its role on plasma lipid and lipoprotein metabolism. J Atheroscler Thromb. 2015; 22: 1001-1011.

13. Goldstein JL, Brown MS. A century of cholesterol and coronaries: From plaques to genes to statins. Cell. 2015; 161: 161-172.

14. Goldstein JL, Hobbs HH, Brown MS. Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B (eds.). Metabolic and molecular bases of inherited disease. Vol II. Chapter 120. New York: McGraw-Hill Publishing Company; 2001. pp. 2863-2913.

15. Anderson RGW, Brown MS, Goldstein JL. Role of the coated endocytic vesicle in the uptake of receptor-bound low-density lipoprotein in human fibroblasts. Cell. 1977; 10: 351-364.

16. Brown MS, Goldstein JL. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell. 1997; 89 (3): 331-340.

17. Fielding CJ. High-density lipoproteins. From basic biology to clinical aspects. Weinheim: Wiley VCH; 2007.

18. Li T, Chiang JY. Regulation of bile acid and cholesterol metabolism by PPARs. PPAR Res. 2009; 2009: 501739.

19. Wang X, Collins HL, Ranalletta M, Fuki IV, Billheimer JT, Rothblat GH et al. Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. J Clin Invest. 2007; 117: 2216-2224.

20. Paromov VM, Morton RE. Lipid transfer inhibitor protein defines the participation of high-density lipoprotein subfractions in lipid transfer reactions mediated by cholesterol ester transfer protein (CETP). J Biol Chem. 2003; 278: 40859-40866.